Skip to main content
Year archive

AFT PHARMACEUTICALS LIMITED — 2022 filings

All 43 regulatory filings released by AFT PHARMACEUTICALS LIMITED (AFP) in 2022, sourced directly from the official regulator.

43 Filings
2022 Period
2022 filings (43)
Filing Released Lang
221124 Interim results FY23H1 release 4 pages 158.9KB
Interim / Quarterly Report
2022-11-23 English
221124 Interim results FY23H1 App 2 2 pages 200.7KB
Interim / Quarterly Report
2022-11-23 English
221124 Interim results FY23H1 interim report 38 pages 5.7MB
Regulatory Filings
2022-11-23 English
221124 Interim results FY23H1 presentation 22 pages 3.2MB
Interim / Quarterly Report
2022-11-23 English
221124 Interim results FY23H1 App 2 amended 2 pages 202.7KB
Earnings Release
2022-11-23 English
AFT to announce half year interim results on Nov 24 1
Report Publication Announcement
2022-10-09 English
AFT update on Maxigesic IV US registration filing 2 pages 116.5KB
Capital/Financing Update
2022-09-01 English
AFT collaborates to develop birthmark medicine 3 pages 123.8KB
Regulatory Filings
2022-08-31 English
2022 ASM address 6 pages 172.8KB
AGM Information
2022-08-04 English
2022 ASM presentation 42 pages 7.0MB
AGM Information
2022-08-04 English
Results of 2022 Annual Shareholder Meeting 1 page 1
Declaration of Voting Results & Voting Rights Announcements
2022-08-04 English
AFP Completes Pascomer Clinical Study and Takes Back Rights 3 pages 303.9KB
Regulatory Filings
2022-07-26 English
Dr Doug Wilson to step down from AFT Board 2 pages 118.4KB
Board/Management Information
2022-07-21 English
RLG:&AFT Pharmaceutical OTC medicines launch in China-Upd 1
Regulatory Filings
2022-07-07 English
AFT and RooLife launch OTC medicines online in China 3 pages 129.0KB
Regulatory Filings
2022-07-06 English
RLG:RLG & AFT launch OTC medicines online in China 3 pages 1.9MB
Regulatory Filings
2022-07-06 English
Notice of Annual Meeting of Shareholders 2022 3 pages 433.5KB
AGM Information
2022-07-04 English
US FDA seeks more information on Maxigesic IV application 2 pages 142.2KB
Regulatory Filings
2022-06-30 English
interests disclosure executive 1 page 434.5KB
Director's Dealing
2022-06-19 English
capital notice 2 pages 133.6KB
Share Issue/Capital Change
2022-06-19 English
Application for quotation of securities - AFP 6 pages 28.2KB
Share Issue/Capital Change
2022-06-19 English
Annual Meeting and Closing Date for Director Nominations 1
AGM Information
2022-05-29 English
Capital Notice 2 pages 133.7KB
Share Issue/Capital Change
2022-05-25 English
Application for quotation of securities - AFP 6 pages 27.8KB
Share Issue/Capital Change
2022-05-25 English
FY2022 results 4 pages 155.7KB
Annual Report
2022-05-22 English
FY2022 App2 2 pages 180.4KB
Earnings Release
2022-05-22 English
FY2022 Annual Report 43 pages 7.7MB
Annual Report
2022-05-22 English
FY2022 presentation 23 pages 5.8MB
Investor Presentation
2022-05-22 English
Annual Report amended 43 pages 7.7MB
Annual Report
2022-05-22 English
Presentation amended 23 pages 5.8MB
Investor Presentation
2022-05-22 English
change of capital notice 2 pages 133.6KB
Share Issue/Capital Change
2022-05-10 English
Application for quotation of securities - AFP 6 pages 27.8KB
Share Issue/Capital Change
2022-05-10 English
capital change notice 2 pages 133.6KB
Share Issue/Capital Change
2022-05-04 English
Officers interest 1 page 433.6KB
Director's Dealing
2022-05-04 English
Application for quotation of securities - AFP 6 pages 28.2KB
Share Issue/Capital Change
2022-05-04 English
AFP to announce full year results on Monday May 23 2022 2 pages 90.9KB
Report Publication Announcement
2022-05-03 English
Capital Change Notice 2 pages 133.2KB
Share Issue/Capital Change
2022-04-27 English
Application for quotation of securities - AFP 6 pages 27.8KB
Share Issue/Capital Change
2022-04-27 English
AFT prevails in comparative advertising judgement 2 pages 125.8KB
Regulatory Filings
2022-04-07 English
AFT notes FDA approval for Pascomer alternative 2 pages 119.8KB
Regulatory Filings
2022-04-04 English
FFC: Farmaforce and AFT Pharmaceuticals Partnership 2 pages 298.7KB
Regulatory Filings
2022-02-22 English
Disclosure of Directors & Senior Managers Relevant Interests 2 pages 436.3KB
Director's Dealing
2022-01-12 English
2022 New Year letter to investors 5 pages 335.2KB
Investor Presentation
2022-01-06 English